2m 2m 2m 2m 2m 2m 2m
Glass Hse- SubRV (GLASF)
OTC
$11.33+$0.21 (+1.89%)
Price as of Jun 03, 2026- $871.4MMarket Cap
- 104.51%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Glass Hse- SubRV (GLASF)
$11.33+$0.21 (+1.89%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 182.0M -9.41% | 200.9M +24.91% | 160.8M +89.50% | 84.9M +22.21% | |
Cost of Revenue | 105.0M +1.47% | 103.5M +29.60% | 79.9M +24.48% | 64.2M +20.09% | |
Gross Profit | 77.0M -20.98% | 97.4M +20.28% | 81.0M +290.93% | 20.7M +29.29% | |
Sales and Marketing Expense | 2.7M +10.38% | 2.4M -14.79% | 2.8M -17.20% | 3.4M -2.92% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 15.8M +4.79% | 15.0M +2.85% | 14.6M +18.91% | 12.3M +158.03% | |
Total Operating Expenses | 93.5M +2.00% | 91.7M -29.76% | 130.5M +69.25% | 77.1M +50.72% | |
Operating Profit | -16.5M -388.18% | 5.7M +111.58% | -49.5M -12.17% | -56.4M +60.49% | |
Interest Income | 288,000 N/A | 0 -100.00% | 45,138 -20.06% | 56,468 -12.91% | |
Interest Expense | N/A N/A | N/A N/A | -9.8M +29.05% | -7.6M +178.00% | |
Interest Income and Expense and Net | 288,000 N/A | 0 +100.00% | -9.8M +29.42% | -7.6M +182.63% | |
Total Nonoperating Income and Expense | -485,000 -108.85% | 5.5M +114.21% | -38.6M -302.63% | 19.0M +595.82% | |
Income before Taxes | -17.0M -251.69% | 11.2M +112.73% | -88.1M +135.92% | -37.3M -9.05% | |
Income Taxes | 11.9M +13.68% | 10.5M +5.58% | 9.9M +326.75% | -4.4M -232.96% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 817,875 0.00% | |
Net Income | -29.7M -5,814.64% | 519,000 +100.53% | -98.3M +198.66% | -32.9M -25.50% | |
Net Income from Continuing Operations Applicable to Common | -17.0M -251.69% | 11.2M +112.73% | -88.1M +135.92% | -37.3M -9.05% | |
Basic EPS and Net Income | -0.55 +161.90% | -0.21 -87.04% | -1.62 +95.18% | -0.83 -26.55% | |
Diluted EPS and Net Income | -0.55 +161.90% | -0.21 -87.04% | -1.62 +95.18% | -0.83 -26.55% | |
Basic Weighted Average Shares | 81.9M +8.92% | 75.2M +4.44% | 72.0M +12.23% | 64.2M +63.55% | |
Diluted Weighted Average Shares | 81.9M +8.92% | 75.2M +4.44% | 72.0M +12.23% | 64.2M +63.55% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 19.9M -41.49% | 33.9M +14.90% | 29.5M +164.95% | 11.1M -78.18% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 19.9M -41.49% | 33.9M +14.90% | 29.5M +164.95% | 11.1M -78.18% | |
Total Current Assets | 67.7M +2.49% | 66.1M +34.31% | 49.2M +26.54% | 38.9M -43.73% | |
Accumulated Depreciation | 58.8M +24.46% | 47.3M +40.80% | 33.6M +64.63% | 20.4M +118.94% | |
Property and Plant and Equipment and Net | 228.8M +7.78% | 212.3M -1.59% | 215.7M -0.34% | 216.4M +10.54% | |
Total Long-Term Assets | 1.1M -78.25% | 4.9M +8.96% | 4.5M -4.68% | 4.7M +100.52% | |
Total Assets | 318.6M +2.59% | 310.5M +2.21% | 303.8M -13.36% | 350.6M +21.71% | |
Income Taxes Payable | 0 -100.00% | 2.4M -69.44% | 7.9M -11.24% | 8.9M +39.35% | |
Total Short-Term Debt | 37,000 -99.52% | 7.6M +1.24% | 7.6M +18,664.63% | 40,237 -99.46% | |
Total Current Liabilities | 38.0M -42.90% | 66.5M -23.90% | 87.4M +61.77% | 54.0M -4.84% | |
Total Long-Term Debt | 68.6M +35.76% | 50.6M -10.55% | 56.5M -9.75% | 62.6M +29.05% | |
Total Long-Term Liabilities | 33.4M +60.11% | 20.9M +283.35% | 5.4M +94.36% | 2.8M +93.29% | |
Total Liabilities | 144.0M -1.70% | 146.4M -7.63% | 158.5M +22.43% | 129.5M +20.79% | |
Retained Earnings | -220.1M +15.58% | -190.4M -0.27% | -190.9M +106.05% | -92.7M +52.34% | |
Total Stockholders Equity | 73.9M -36.39% | 116.2M +29.50% | 89.8M -46.84% | 168.9M -6.74% | |
Total Shares Outstanding | 4.8M 0.00% | 4.8M -93.72% | 75.7M +3.73% | 73.0M +18.51% | |
Cash Flow | |||||
Cash from Operating Activities | 11.4M -59.68% | 28.4M +22.25% | 23.2M +156.94% | -40.8M +101.06% | |
Capital Expenditures | 27.2M +164.03% | 10.3M -16.37% | 12.3M -55.67% | 27.8M -74.41% | |
Cash from Investing Activities | -27.7M +169.50% | -10.3M -19.03% | -12.7M -56.46% | -29.2M -73.81% | |
Dividends Paid | -342,000 +213.76% | -109,000 -40.16% | -182,151 N/A | N/A N/A | |
Cash from Financing Activities | 2.7M +119.87% | -13.7M -274.05% | 7.9M -73.82% | 30.1M -83.42% | |
Financials Ratio | |||||
Gross Margin | 42.29% -12.77% | 48.48% -3.70% | 50.34% +106.30% | 24.40% N/A | |
Operating Margin | -9.08% -418.13% | 2.86% +109.27% | -30.79% -53.65% | -66.44% N/A | |
Return on Assets | -9.43% -5,679.64% | 0.17% +100.56% | -30.03% +191.50% | -10.30% N/A | |
Return on Equity | -31.19% -6,290.08% | 0.50% +100.66% | -75.99% +304.11% | -18.81% N/A | |
Revenue Growth | -9.41% -137.80% | 24.91% -72.17% | 89.50% +302.89% | 22.21% N/A | |
Current Ratio | 1.78 +79.50% | 0.99 +76.48% | 0.56 -21.77% | 0.72 N/A | |
Cash Ratio | 0.52 +2.47% | 0.51 +50.98% | 0.34 +63.76% | 0.21 N/A | |
Debt-to-Equity Ratio | 0.93 +85.48% | 0.50 -29.84% | 0.71 +92.32% | 0.37 N/A | |
Debt-to-Assets Ratio | 0.22 +15.05% | 0.19 -11.14% | 0.21 +18.02% | 0.18 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow